BPMC
Price
$127.82
Change
-$0.08 (-0.06%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
8.26B
54 days until earnings call
TBPH
Price
$11.26
Change
+$0.49 (+4.55%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
562.52M
66 days until earnings call
Interact to see
Advertisement

BPMC vs TBPH

Header iconBPMC vs TBPH Comparison
Open Charts BPMC vs TBPHBanner chart's image
Blueprint Medicines
Price$127.82
Change-$0.08 (-0.06%)
Volume$92.19K
Capitalization8.26B
Theravance Biopharma
Price$11.26
Change+$0.49 (+4.55%)
Volume$9.99K
Capitalization562.52M
BPMC vs TBPH Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. TBPH commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Buy and TBPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BPMC: $127.92 vs. TBPH: $10.78)
Brand notoriety: BPMC and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 171% vs. TBPH: 88%
Market capitalization -- BPMC: $8.26B vs. TBPH: $562.52M
BPMC [@Biotechnology] is valued at $8.26B. TBPH’s [@Biotechnology] market capitalization is $562.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 6 TA indicator(s) are bullish while TBPH’s TA Score has 6 bullish TA indicator(s).

  • BPMC’s TA Score: 6 bullish, 4 bearish.
  • TBPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BPMC and TBPH are a good buy in the short-term.

Price Growth

BPMC (@Biotechnology) experienced а +24.12% price change this week, while TBPH (@Biotechnology) price change was +15.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.26B) has a higher market cap than TBPH($563M). BPMC YTD gains are higher at: 46.664 vs. TBPH (14.559). TBPH has higher annual earnings (EBITDA): -38.45M vs. BPMC (-66.42M). BPMC has more cash in the bank: 576M vs. TBPH (88.4M). TBPH has less debt than BPMC: TBPH (49.8M) vs BPMC (467M). BPMC has higher revenues than TBPH: BPMC (562M) vs TBPH (64.4M).
BPMCTBPHBPMC / TBPH
Capitalization8.26B563M1,467%
EBITDA-66.42M-38.45M173%
Gain YTD46.66414.559321%
P/E RatioN/AN/A-
Revenue562M64.4M873%
Total Cash576M88.4M652%
Total Debt467M49.8M938%
FUNDAMENTALS RATINGS
BPMC vs TBPH: Fundamental Ratings
BPMC
TBPH
OUTLOOK RATING
1..100
7758
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
51100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
3844
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for BPMC (82) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (51) in the Biotechnology industry is somewhat better than the same rating for TBPH (100) in the Pharmaceuticals Other industry. This means that BPMC’s stock grew somewhat faster than TBPH’s over the last 12 months.

TBPH's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as BPMC (94) in the Biotechnology industry. This means that TBPH’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Price Growth Rating (38) in the Biotechnology industry is in the same range as TBPH (44) in the Pharmaceuticals Other industry. This means that BPMC’s stock grew similarly to TBPH’s over the last 12 months.

BPMC's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for TBPH (100) in the Pharmaceuticals Other industry. This means that BPMC’s stock grew somewhat faster than TBPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 22 days ago
73%
Bullish Trend 18 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHVCX12.920.01
+0.08%
Cullen High Dividend Equity C
MFQTX17.87N/A
N/A
AMG Veritas Global Focus I
SVAIX6.09N/A
N/A
Federated Hermes Strategic Value Div IS
HDIVX17.90N/A
N/A
Janus Henderson Responsible Intl Div I
PMJIX10.44N/A
N/A
PIMCO RAE US Small Instl

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with LYRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-0.14%
LYRA - BPMC
44%
Loosely correlated
+9.07%
ORIC - BPMC
42%
Loosely correlated
+0.88%
INSM - BPMC
42%
Loosely correlated
-1.29%
ARQT - BPMC
42%
Loosely correlated
+1.81%
AXON - BPMC
41%
Loosely correlated
+1.08%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-2.09%
KYMR - TBPH
40%
Loosely correlated
+7.68%
ELEV - TBPH
39%
Loosely correlated
-0.99%
BPMC - TBPH
38%
Loosely correlated
-0.14%
VERA - TBPH
37%
Loosely correlated
-4.27%
AXON - TBPH
34%
Loosely correlated
+1.08%
More